Rock Creek Pharmaceuticals, Inc. (RCPIQ) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
2040 WHITFIELD AVENUE SARASOTA, FL 34243 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2016 MRQ | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 493 | 395 | 3,881 | 23,121 | |||
| Cash and cash equivalents | 493 | 395 | 3,881 | 23,121 | |||
| Receivables | 62 | 66 | |||||
| Inventory, net of allowances, customer advances and progress billings | 3,473 | 4,989 | |||||
| Inventory | 3,473 | 4,989 | |||||
| Prepaid expense | 671 | ✕ | |||||
| Disposal group, including discontinued operation | 3 | 6 | 51 | ||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | 1,089 | ||
| Other undisclosed current assets | 485 | 6,729 | 1,593 | 33 | |||
| Total current assets: | 1,043 | 7,801 | 9,013 | 29,283 | |||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 170 | 207 | 399 | 1,338 | |||
| Long-term investments and receivables | 517 | ||||||
| Accounts and financing receivable, after allowance for credit loss | 517 | ||||||
| Intangible assets, net (including goodwill) | 55 | 402 | 472 | 541 | |||
| Intangible assets, net (excluding goodwill) | 55 | 402 | 472 | 541 | |||
| Restricted cash and investments | 17,295 | ||||||
| Disposal group, including discontinued operation, noncurrent assets | 24 | 25 | ✕ | ✕ | |||
| Deferred costs | 478 | ||||||
| Other undisclosed noncurrent assets | 482 | 482 | 551 | 762 | |||
| Total noncurrent assets: | 18,504 | 1,116 | 1,939 | 2,641 | |||
| TOTAL ASSETS: | 19,547 | 8,917 | 10,952 | 31,924 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 9,360 | 21,951 | 1,812 | 2,717 | |||
| Settlement liabilities | 6,679 | ✕ | ✕ | ||||
| Employee-related liabilities | 3,132 | ||||||
| Accounts payable | 5,475 | 3,211 | |||||
| Accrued liabilities | 3,885 | 8,929 | 1,812 | 2,717 | |||
| Debt | 12,350 | 7 | |||||
| Disposal group, including discontinued operation | 433 | 533 | 29 | 1,761 | |||
| Due to related parties | 50 | 50 | |||||
| Other undisclosed current liabilities | (3,132) | 2,132 | 2,455 | ||||
| Total current liabilities: | 22,193 | 19,402 | 3,973 | 6,940 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 8,000 | 350 | |||||
| Long-term debt, excluding current maturities | 8,000 | 350 | |||||
| Total noncurrent liabilities: | 8,000 | 350 | |||||
| Total liabilities: | 30,193 | 19,752 | 3,973 | 6,940 | |||
| Equity | |||||||
| Equity, attributable to parent | (10,646) | (10,835) | 6,979 | 24,984 | |||
| Common stock | 1 | 19 | 17 | 17 | |||
| Additional paid in capital | 299,290 | 292,028 | 271,327 | 256,498 | |||
| Accumulated deficit | (309,937) | (302,882) | (264,365) | (231,531) | |||
| Total equity: | (10,646) | (10,835) | 6,979 | 24,984 | |||
| TOTAL LIABILITIES AND EQUITY: | 19,547 | 8,917 | 10,952 | 31,924 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2016 TTM | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|
| Revenues | 1,360 | 9,141 | 6,188 | |||
| Revenue, net | 9,141 | 6,188 | ||||
| Financial services revenue | 1,360 | |||||
| Cost of revenue (Cost of Goods and Services Sold) | (65) | (5,493) | (3,744) | |||
| Other undisclosed gross profit | 319 | 178 | ||||
| Gross profit: | 1,360 | (65) | 3,967 | 2,622 | ||
| Operating expenses | (11,315) | (32,579) | (36,890) | (27,235) | ||
| Other undisclosed operating income (loss) | (1,360) | 65 | ||||
| Operating loss: | (11,315) | (32,579) | (32,923) | (24,613) | ||
| Nonoperating income (expense) | 4,552 | (537) | (306) | 6,513 | ||
| Other nonoperating income (expense) | 3,601 | (558) | (320) | 6,600 | ||
| Interest and debt expense | (42) | (1) | (104) | |||
| Loss from continuing operations before equity method investments, income taxes: | (6,805) | (33,117) | (33,229) | (18,204) | ||
| Other undisclosed income from continuing operations before income taxes | 42 | 1 | 104 | |||
| Loss from continuing operations: | (6,763) | (33,116) | (33,229) | (18,100) | ||
| Loss before gain (loss) on sale of properties: | (6,845) | (38,517) | (33,229) | (18,100) | ||
| Loss from discontinued operations | (82) | (5,401) | ||||
| Net loss: | (6,845) | (38,517) | (33,229) | (18,100) | ||
| Other undisclosed net income (loss) attributable to parent | 395 | (4,753) | ||||
| Net loss available to common stockholders, diluted: | (6,845) | (38,517) | (32,834) | (22,853) | ||
Comprehensive Income ($ in thousands)
| 6/30/2016 TTM | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|
| Net loss: | (6,845) | (38,517) | (33,229) | (18,100) | ||
| Comprehensive loss, net of tax, attributable to parent: | (6,845) | (38,517) | (33,229) | (18,100) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.